Additionally, defective signaling was identified in isolated B-cells from patients with SLE, and combination treatment of anti-IgM antibody and CD40L failed to reduce CXCR4 expression compared with healthy controls [71]. The gene discussed is CD40LG; the disease is systemic lupus erythematosus.